<DOC>
	<DOCNO>NCT01326650</DOCNO>
	<brief_summary>Despite significant therapeutic improvement , congestive heart failure ( CHF ) patient still poor prognosis . Currently , 5-year survival rate 35-50 % . There accumulate body evidence prospective cohort study low circulate 25-hydroxyvitamin D independent predictor all-cause cardiovascular mortality , respectively . Vitamin D deficiency prevalent among CHF patient . We hypothesize vitamin D may improve survival CHF patient . We therefore aim investigate whether vitamin D supplementation reduce mortality increase event-free survival end-stage CHF patient .</brief_summary>
	<brief_title>Vitamin D Mortality Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>&gt; 18 year age &lt; 80 year age New York Heart Association Functional Class &gt; = II pregnancy lactation sarcoidosis daily vitamin D intake &gt; 20 microgram serum 25hydroxyvitamin D &gt; 30 ng/ml hypercalcemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>vitamin D , mortality , event-free survival , heart failure</keyword>
</DOC>